Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1CNS 1

Conditions

Rectal Neoplasms 1Neoplasms 1Glioma 1Glioblastoma 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Karnofsky Performance Status × Clear all
NCT02663271 2022-06-23

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

University of Florida

Phase 2 Terminated
10 enrolled 13 charts
CNS

Glioblastoma, Glioma

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Clinical Research Support Center Kyush

Phase 2 Unknown
110 enrolled
Gastrointestinal

Rectal Neoplasms

NCT00735111 2013-01-17

Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores?

University of Florida

Phase NA Completed
200 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡